关注
Nayab Tahir
Nayab Tahir
Post doc Research Fellow, Massachusetts General Hospital, Harvard Medical School,
在 uos.edu.pk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Liposomal drug delivery: a versatile platform for challenging clinical applications
A Madni, M Sarfraz, M Rehman, M Ahmad, N Akhtar, S Ahmad, N Tahir, ...
Journal of Pharmacy & Pharmaceutical Sciences 17 (3), 401-426, 2014
1892014
Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin
MM Khan, A Madni, V Torchilin, N Filipczak, J Pan, N Tahir, H Shah
Drug delivery 26 (1), 765-772, 2019
1222019
Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications
N Tahir, A Madni, V Balasubramanian, M Rehman, A Correia, PM Kashif, ...
International journal of pharmaceutics 533 (1), 156-168, 2017
1202017
Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
N Tahir, A Madni, A Correia, M Rehman, V Balasubramanian, MM Khan, ...
International journal of nanomedicine, 4961-4974, 2019
842019
Non-invasive strategies for targeting the posterior segment of eye
A Madni, MA Rahem, N Tahir, M Sarfraz, A Jabar, M Rehman, PM Kashif, ...
International journal of pharmaceutics 530 (1-2), 326-345, 2017
692017
Graphene-based nanocomposites: synthesis and their theranostic applications
A Madni, S Noreen, I Maqbool, F Rehman, A Batool, PM Kashif, ...
Journal of Drug Targeting 26 (10), 858-883, 2018
682018
Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery
N Tahir, A Madni, W Li, A Correia, MM Khan, MA Rahim, HA Santos
International Journal of Pharmaceutics 581, 119275, 2020
672020
Co-delivery of curcumin and cisplatin to enhance cytotoxicity of cisplatin using lipid-chitosan hybrid nanoparticles
MM Khan, A Madni, N Tahir, F Parveen, S Khan, N Jan, A Ali, ...
International Journal of Nanomedicine, 2207-2217, 2020
582020
Novel nanoparticulate systems for lung cancer therapy: an updated review
A Madni, A Batool, S Noreen, I Maqbool, F Rehman, PM Kashif, N Tahir, ...
Journal of drug targeting 25 (6), 499-512, 2017
452017
Enhanced blood brain barrier permeability and glioblastoma cell targeting via thermoresponsive lipid nanoparticles
M Rehman, A Madni, D Shi, A Ihsan, N Tahir, KR Chang, I Javed, ...
Nanoscale 9 (40), 15434-15440, 2017
422017
Enhancement of dissolution and skin permeability of pentazocine by proniosomes and niosomal gel
A Madni, MA Rahim, MA Mahmood, A Jabar, M Rehman, H Shah, A Khan, ...
AAPS PharmSciTech 19, 1544-1553, 2018
412018
Hybrid Nano-carriers for potential drug delivery
A Madni, N Tahir, M Rehman, A Raza, MA Mahmood, MI Khan, PM Kashif
Advanced technology for delivering therapeutics, 54-87, 2017
322017
Development of Eudragit RS 100 Microparticles Loaded with Ropinirole: Optimization and In Vitro Evaluation Studies
PM Kashif, A Madni, M Ashfaq, M Rehman, MA Mahmood, MI Khan, ...
AAPS pharmscitech 18, 1810-1822, 2017
292017
Development and In Vitro/Ex Vivo Evaluation of Lecithin‐Based Deformable Transfersomes and Transfersome‐Based Gels for Combined Dermal Delivery of …
MI Khan, S Yaqoob, A Madni, MF Akhtar, MF Sohail, A Saleem, N Tahir, ...
BioMed Research International 2022 (1), 8170318, 2022
182022
Statistically optimized pentazocine loaded microsphere for the sustained delivery application: Formulation and characterization
A Jabar, A Madni, S Bashir, N Tahir, F Usman, MA Rahim, N Jan, H Shah, ...
PloS one 16 (4), e0250876, 2021
172021
Drug-Polymer Interaction Studies of Cytarabine Loaded Chitosan Nanoparticles.
A Madni, PM Kashif, I Nazir, N Tahir, M Rehman, MI Khan, MA Rahim, ...
Journal of the Chemical Society of Pakistan 39 (6), 2017
172017
Lipid polymer hybrid nanoparticles: a novel approach for drug delivery
N Tahir, MT Haseeb, A Madni, F Parveen, MM Khan, S Khan, N Jan, ...
Role of Novel Drug Delivery Vehicles in Nanobiomedicine, 59, 2019
162019
Mild hyperthermia responsive liposomes for enhanced in vitro and in vivo anticancer efficacy of doxorubicin against hepatocellular carcinoma
MA Rahim, A Madni, N Tahir, N Jan, H Shah, S Khan, R Ullah, A Bari, ...
Pharmaceutics 13 (8), 1310, 2021
152021
Determination of tenoxicam in the plasma by reverse phase HPLC method using single step extraction technique: a reliable and cost effective approach
MA Madni, A Raza, S Abbas, N Tahir, M Rehman, PM Kashif, MI Khan
Acta Pol Pharm 73 (5), 1129-1134, 2016
102016
Cell–nanoparticle interactions: toxicity and safety issues
F Fontana, NZ Ezazi, N Tahir, HA Santos
Characterization of Pharmaceutical Nano and Microsystems, 207-242, 2021
72021
系统目前无法执行此操作,请稍后再试。
文章 1–20